Abzena Share News (ABZA)

Abzena Shares Suspended As Acquisition Becomes Effective (ALLISS)

LONDON (Alliance News) - Abzena PLC shares were suspended from trading on AIM on Thursday as the company's acquisition by Astro BidCo Ltd became effective.The biopharmaceutical firm its

UK Shareholder Meetings Calendar - Next 7 Days

Tuesday 11 SeptemberAshtead GroupBilbyCohortMulberry 12 Direct Oil & UK 13 14 UK

WINNERS & LOSERS SUMMARY: Acquisition Puts On The Beach On Buying Wave

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - down 2.6%, Legal & down down 0.7%,

Abzena agrees to be taken over by US private equity firm WCAS

(Sharecast News) - Abzena has agreed to be taken over by US private equity firm WCAS in a £34.4m deal.

Abzena To Go Private As It Agrees GBP34 Million Takeover By Astro

LONDON (Alliance News) - Shares in biopharmaceutical technology firm Abzena PLC rocketed Thursday after agreed to a takeover valuing the firm at around GBP34.4 million.Astro Bidco Ltd, a up

Shares In Abzena Fall As It Seeks To Monetise Royalty-Bearing Products

LONDON (Alliance News) - Abzena PLC on Thursday said it has entered into a non-binding heads of terms agreement with an unconnected third party as it requires additional funding to support its in

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2.6%. The jet engine maker said it will cut

WINNERS & LOSERS SUMMARY: Shares Of Upbeat Synthomer Hit Record High

Abzena signs licensing agreement for 'ThioBridge' technology

(ShareCast News) - Life sciences group Abzena announced on Friday that it has signed a licensing agreement with an unnamed San Diego-based biopharmaceutical company for its site-specific 'ThioBridge' antibody drug conjugate linker technology. The AIM-traded company said 'ThioBridge' links antibodies

Abzena Shares Jump On ThioBridge Licensing Agreement In US

Abzena inks licence agreement with Trieza Therapeutics

(ShareCast News) - Life-sciences group Abzena has inked a licence agreement with start-up biotechnology company Trieza Therapeutics. US-based Trieza specialises in the discovery and development of immunomodulatory oncolytic viruses. Abzena has granted Trieza an exclusive licence to an undisclosed a

Abzena shares plunge as Gilead drops simtuzumab

(ShareCast News) - Life sciences group Abzena noted on Wednesday that during Gilead Sciences' announcement of third quarter earnings on 1 November, it stated that no further development of simtuzumab will be pursued. The AIM-traded firm also noted that GS-5745 will not be progressed further by Gilea

Abzena notes progress with Composite Human Antibody tech

(ShareCast News) - Life sciences group Abzena noted on Friday that Gilead Sciences has announced top line Phase II clinical study results of its product, GS-4997 (selonsertib) in combination with the investigational monoclonal antibody, simtuzumab (SIM) or SIM alone, in patients with non-alcoholic s

UK Shareholder Meetings Calendar - Next 7 Days